- Published on
Ophthalmology – Epiphora
Epiphora, or excessive tearing, represents an imbalance between tear production and tear drainage. Tears are produced primarily by the lacrimal and accessory lacrimal glands and normally drain through the puncta, canaliculi, lacrimal sac, and nasolacrimal duct into the nose. Epiphora therefore develops either because of excessive tear production, usually from ocular surface irritation, or because of impaired tear drainage.
Epiphora can occur at any age but has a bimodal distribution, being particularly common in infancy and later adulthood. In infants, the most frequent cause is congenital nasolacrimal duct obstruction, occurring in approximately 5% of infants. About 90% resolve spontaneously by 1 year of age. In adults, tearing is common and frequently results from dry eye with reflex tearing, particularly in women after menopause.
Normally, aqueous tears mix with lipid secretions from the meibomian glands and mucins to form a stable tear film. Blinking distributes this tear film and generates a pumping action that moves tears through the lacrimal drainage system. Disruption at any point can produce epiphora. Congenital nasolacrimal duct obstruction results from incomplete canalization of the nasolacrimal duct during embryologic development.
In adults, an unstable tear film or dry eye disease can irritate the ocular surface and paradoxically stimulate excessive reflex tearing. Blepharitis and meibomian gland dysfunction may contribute. Other causes of reflex tearing include trichiasis, entropion, corneal foreign bodies, keratitis, uveitis, and conjunctivitis. Lower eyelid laxity or ectropion can impair the normal lacrimal pump. Acquired obstruction can occur anywhere along the drainage system because of infection, inflammation, trauma, or medication-related stenosis, including that caused by certain chemotherapeutic agents.
Common associated conditions include blepharitis, dry eye, trichiasis, entropion, ectropion, nasolacrimal drainage obstruction, ocular surface inflammation, and foreign bodies.
Diagnosis
Infants with congenital nasolacrimal duct obstruction typically develop persistent unilateral or bilateral tearing shortly after birth. Crusting and discharge around the eyelashes are common, particularly after sleep, and symptoms may become worse during nasal congestion.
Adults with dry eye typically describe intermittent tearing with a gradual onset. Symptoms may worsen during activities that reduce blinking, such as reading, computer use, watching television, and driving, as well as in cold or windy environments. In contrast, patients with a dysfunctional tear pump or an anatomic drainage obstruction generally experience more constant tearing. A history of dacryocystitis, ocular infection, trauma, or previous surgery may suggest an acquired obstruction.
Physical examination should assess the quality and quantity of the tear film, eyelid position and laxity, punctal position, eyelashes, and ocular surface. The examiner should specifically look for trichiasis, entropion, ectropion, conjunctivitis, keratitis, foreign bodies, and signs of dry eye. The puncta, canaliculi, lacrimal sac, and nasolacrimal duct should also be evaluated. Palpation of the lacrimal sac is particularly important when distal obstruction is suspected.
The fluorescein dye disappearance test provides a simple assessment of tear drainage. Fluorescein is placed in the conjunctival cul-de-sac and evaluated after approximately 5 minutes. Normally, most dye disappears as tears drain through the lacrimal system. Persistence or increasing height of the fluorescein-stained tear meniscus suggests impaired drainage.
The Schirmer test can evaluate aqueous tear production. When performed with topical anesthesia to assess basal secretion, less than approximately 5 mm of wetting in 5 minutes suggests aqueous tear deficiency, 5–10 mm is borderline, and greater than 10 mm is generally considered normal.
Additional testing depends on the suspected cause. Patients with dry mouth or systemic rheumatologic symptoms may require evaluation for Sjögren syndrome. Lacrimal irrigation can identify obstruction in teenagers and adults. Dacryocystography may help distinguish mechanical obstruction from tear-pump dysfunction, while lacrimal scintigraphy can assess functional drainage. CT imaging may be appropriate when a dacryocele, nasolacrimal cyst, lacrimal sac tumor, or another structural lesion is suspected.
Moderate or severe dry eye may produce punctate staining of the exposed cornea and conjunctiva. A distended lacrimal sac that produces purulent material through the puncta when compressed strongly suggests chronic dacryocystitis associated with nasolacrimal duct obstruction.
The differential diagnosis varies with age and presentation. Chronic tearing in children includes congenital nasolacrimal duct obstruction, congenital glaucoma, and epiblepharon, while acute tearing may result from conjunctivitis, keratitis, or a foreign body. Chronic adult causes include dry eye, acquired nasolacrimal duct obstruction, ectropion, entropion, trichiasis, and previous facial nerve palsy. Acute adult causes include conjunctivitis, keratitis, uveitis, foreign bodies, and acute facial nerve palsy. Importantly, infantile glaucoma should not be overlooked in a persistently tearing infant.
Treatment
Treatment is directed at the underlying cause rather than tearing itself. Infants with congenital nasolacrimal duct obstruction are usually managed initially with observation and lacrimal sac massage. Topical antibiotic ointment, such as erythromycin, may be used when significant mucopurulent discharge or crusting is present, although antibiotics do not correct the underlying obstruction.
Adults with dry-eye-related reflex tearing are generally treated initially with artificial tears and management of associated blepharitis or meibomian gland dysfunction. More persistent inflammatory dry eye may require treatments such as topical anti-inflammatory therapy. Foreign bodies, trichiasis, bacterial conjunctivitis, keratitis, and other identifiable causes should be treated specifically.
Procedural treatment depends on the anatomical abnormality. Punctal stenosis may require punctoplasty, while persistent congenital nasolacrimal obstruction may require probing and irrigation, lacrimal intubation, or balloon dacryoplasty. More severe obstruction may require dacryocystorhinostomy (DCR) or, in selected cases, conjunctivodacryocystorhinostomy. Adults with nasolacrimal obstruction may similarly require punctoplasty, probing with stenting, balloon dacryoplasty, or DCR. When eyelid malposition or pump failure is responsible, entropion repair, ectropion repair, or horizontal eyelid tightening may be necessary.
Follow-up and Prognosis
Infants with uncomplicated congenital nasolacrimal duct obstruction can generally be observed during the first year of life, because most cases resolve spontaneously. Persistent obstruction beyond this period may require procedural intervention. Acute dacryocystitis, particularly in an infant, requires prompt ophthalmologic assessment.
Adults are followed according to the underlying cause and severity. Dry eye and blepharitis frequently produce chronic or intermittent symptoms, whereas anatomical obstruction or eyelid malposition may require surgery followed by postoperative monitoring.
Parents should be instructed in the correct technique for nasolacrimal sac massage when treating congenital obstruction. Adults with blepharitis may benefit from regular eyelid hygiene and warm compresses.
The prognosis is excellent in most pediatric cases. Adult prognosis depends on the etiology. Dry eye and blepharitis may cause recurrent symptoms, whereas patients with significant nasolacrimal duct obstruction generally have a good outcome following appropriate DCR surgery.
- Published on
Ophthalmology – Dry Eye Syndrome (Keratoconjunctivitis Sicca)
Dry eye syndrome is a multifactorial disease of the ocular surface characterized by an unstable or insufficient tear film, leading to discomfort, visual disturbance, and potential damage to the cornea and conjunctiva. It is broadly classified into three main types: aqueous tear-deficient, evaporative, and exposure-related dry eye. The condition may occur as an isolated ocular disorder or as part of systemic diseases such as autoimmune conditions.
This is a very common condition, particularly in older adults and females. Prevalence increases with age, affecting up to 19% of individuals over 80 years. Risk factors include aging, female sex, ocular surgeries (such as LASIK or cataract surgery), diabetes, and contact lens use. Environmental factors like low humidity and prolonged screen use also contribute significantly.
The pathophysiology involves tear film instability and ocular surface desiccation, which leads to inflammation, loss of goblet cells, and epithelial damage. Over time, this can result in keratinization and chronic surface changes. In aqueous deficiency, there is reduced tear production, whereas evaporative dry eye is usually due to meibomian gland dysfunction, causing rapid tear evaporation. Exposure-related dry eye results from incomplete eyelid closure or reduced blinking.
Patients commonly report burning, itching, gritty sensation, foreign body sensation, and intermittent blurred vision, especially with prolonged visual tasks like reading or computer use. Symptoms often worsen in dry, windy, or air-conditioned environments and improve in humid conditions. Some patients paradoxically experience excess tearing, which is a reflex response to irritation.
On examination, findings may include conjunctival redness, reduced tear meniscus, and superficial punctate keratitis in exposed areas of the cornea. In evaporative dry eye, signs of meibomian gland dysfunction such as thickened secretions, lid margin inflammation, and foamy tear film may be present. Severe cases may show filamentary keratitis or epithelial defects.
Diagnosis is supported by clinical tests. The Schirmer test measures tear production, with low values indicating aqueous deficiency. The tear breakup time (TBUT) assesses tear film stability, with values less than 10 seconds suggesting evaporative dry eye. Rose Bengal staining highlights damaged or devitalized epithelial cells and helps assess severity.
Management is stepwise and depends on severity and type. First-line treatment includes artificial tears, gels, and ointments to supplement and preserve moisture. Environmental modifications such as using humidifiers and avoiding irritants are also important. For evaporative causes, warm compresses and lid hygiene are essential, and oral doxycycline or omega-3 supplements may be beneficial.
Second-line therapies include topical cyclosporine, autologous serum eye drops, and systemic secretagogues such as pilocarpine or cevimeline in selected cases. In more severe disease, procedures such as punctal plugs or punctal occlusion help retain tears. For exposure-related cases, interventions like lid taping, moisture chambers, or surgical options (e.g., tarsorrhaphy) may be required.
Patients should be advised to stay hydrated, blink frequently during screen use, and avoid dry environments. Referral to a specialist is indicated if systemic conditions like Sjögren’s syndrome are suspected.
The prognosis is generally excellent, with most patients achieving good symptom control with appropriate therapy. However, untreated or severe cases can lead to complications such as filamentary keratitis, corneal ulceration, or rarely corneal perforation, highlighting the importance of early recognition and management.
Dry eye syndrome is a multifactorial disease of the ocular surface characterized by an unstable or insufficient tear film, leading to discomfort, visual disturbance, and potential damage to the cornea and conjunctiva. It is broadly classified into three main types: aqueous tear-deficient, evaporative, and exposure-related dry eye. The condition may occur as an isolated ocular disorder or as part of systemic diseases such as autoimmune conditions.
This is a very common condition, particularly in older adults and females. Prevalence increases with age, affecting up to 19% of individuals over 80 years. Risk factors include aging, female sex, ocular surgeries (such as LASIK or cataract surgery), diabetes, and contact lens use. Environmental factors like low humidity and prolonged screen use also contribute significantly.
The pathophysiology involves tear film instability and ocular surface desiccation, which leads to inflammation, loss of goblet cells, and epithelial damage. Over time, this can result in keratinization and chronic surface changes. In aqueous deficiency, there is reduced tear production, whereas evaporative dry eye is usually due to meibomian gland dysfunction, causing rapid tear evaporation. Exposure-related dry eye results from incomplete eyelid closure or reduced blinking.
Patients commonly report burning, itching, gritty sensation, foreign body sensation, and intermittent blurred vision, especially with prolonged visual tasks like reading or computer use. Symptoms often worsen in dry, windy, or air-conditioned environments and improve in humid conditions. Some patients paradoxically experience excess tearing, which is a reflex response to irritation.
On examination, findings may include conjunctival redness, reduced tear meniscus, and superficial punctate keratitis in exposed areas of the cornea. In evaporative dry eye, signs of meibomian gland dysfunction such as thickened secretions, lid margin inflammation, and foamy tear film may be present. Severe cases may show filamentary keratitis or epithelial defects.
Diagnosis is supported by clinical tests. The Schirmer test measures tear production, with low values indicating aqueous deficiency. The tear breakup time (TBUT) assesses tear film stability, with values less than 10 seconds suggesting evaporative dry eye. Rose Bengal staining highlights damaged or devitalized epithelial cells and helps assess severity.
Management is stepwise and depends on severity and type. First-line treatment includes artificial tears, gels, and ointments to supplement and preserve moisture. Environmental modifications such as using humidifiers and avoiding irritants are also important. For evaporative causes, warm compresses and lid hygiene are essential, and oral doxycycline or omega-3 supplements may be beneficial.
Second-line therapies include topical cyclosporine, autologous serum eye drops, and systemic secretagogues such as pilocarpine or cevimeline in selected cases. In more severe disease, procedures such as punctal plugs or punctal occlusion help retain tears. For exposure-related cases, interventions like lid taping, moisture chambers, or surgical options (e.g., tarsorrhaphy) may be required.
Patients should be advised to stay hydrated, blink frequently during screen use, and avoid dry environments. Referral to a specialist is indicated if systemic conditions like Sjögren’s syndrome are suspected.
The prognosis is generally excellent, with most patients achieving good symptom control with appropriate therapy. However, untreated or severe cases can lead to complications such as filamentary keratitis, corneal ulceration, or rarely corneal perforation, highlighting the importance of early recognition and management.
- Published on
Ophthalmology – Down Syndrome (Trisomy 21)
Down syndrome, also known as Trisomy 21, is a chromosomal disorder caused by the presence of an extra copy of chromosome 21. It was first described by John Langdon Down in 1866. The condition affects individuals worldwide across all ethnic and socioeconomic groups and is one of the most common genetic causes of intellectual disability.
The incidence is approximately 1 in 733 live births in the United States, with risk strongly associated with advanced maternal age. For example, the risk increases significantly from about 1 in 1,562 in women aged 20–24 to about 1 in 19 in women over 45. Increased paternal age has also been identified as a contributing risk factor. Most cases result from meiotic nondisjunction, leading to a full extra chromosome, although partial or mosaic forms may also occur.
Clinically, Down syndrome presents with a characteristic set of physical features. These include a round face, small chin (microgenia), macroglossia (large tongue), and short neck. Ocular findings are particularly relevant in ophthalmology and include epicanthal folds, upward slanting palpebral fissures, and Brushfield spots—small whitish or grayish speckles seen at the periphery of the iris. Patients often also have strabismus, cataracts, and other visual abnormalities. General features include hypotonia, short stature, single palmar crease, and varying degrees of intellectual disability and speech delay.
Down syndrome is associated with multiple systemic conditions. These include thyroid disorders, gastrointestinal anomalies, hematologic malignancies, and an increased risk of early-onset Alzheimer’s disease, often developing before age 50. Fertility is typically reduced, especially in males.
Diagnosis can be made prenatally through screening and diagnostic techniques such as amniocentesis, chorionic villus sampling, or umbilical cord blood sampling. Postnatally, diagnosis is confirmed by karyotype analysis. Ophthalmic evaluation may include imaging such as optical coherence tomography (OCT), which can demonstrate macular hypoplasia, and visual electrophysiologic testing.
There is no cure for Down syndrome, so management focuses on supportive care and treatment of associated conditions. Early intervention programs, including speech therapy, occupational therapy, and educational support, significantly improve developmental outcomes. Ophthalmic issues such as strabismus or cataracts should be managed appropriately to optimize visual function.
Follow-up care is lifelong and multidisciplinary. With advances in medical care and supportive services, life expectancy has improved significantly, increasing from approximately 25 years in 1980 to nearly 50 years or more today. Many individuals now live into adulthood with improved quality of life, although neurodegenerative complications remain a concern later in life.
Down syndrome, also known as Trisomy 21, is a chromosomal disorder caused by the presence of an extra copy of chromosome 21. It was first described by John Langdon Down in 1866. The condition affects individuals worldwide across all ethnic and socioeconomic groups and is one of the most common genetic causes of intellectual disability.
The incidence is approximately 1 in 733 live births in the United States, with risk strongly associated with advanced maternal age. For example, the risk increases significantly from about 1 in 1,562 in women aged 20–24 to about 1 in 19 in women over 45. Increased paternal age has also been identified as a contributing risk factor. Most cases result from meiotic nondisjunction, leading to a full extra chromosome, although partial or mosaic forms may also occur.
Clinically, Down syndrome presents with a characteristic set of physical features. These include a round face, small chin (microgenia), macroglossia (large tongue), and short neck. Ocular findings are particularly relevant in ophthalmology and include epicanthal folds, upward slanting palpebral fissures, and Brushfield spots—small whitish or grayish speckles seen at the periphery of the iris. Patients often also have strabismus, cataracts, and other visual abnormalities. General features include hypotonia, short stature, single palmar crease, and varying degrees of intellectual disability and speech delay.
Down syndrome is associated with multiple systemic conditions. These include thyroid disorders, gastrointestinal anomalies, hematologic malignancies, and an increased risk of early-onset Alzheimer’s disease, often developing before age 50. Fertility is typically reduced, especially in males.
Diagnosis can be made prenatally through screening and diagnostic techniques such as amniocentesis, chorionic villus sampling, or umbilical cord blood sampling. Postnatally, diagnosis is confirmed by karyotype analysis. Ophthalmic evaluation may include imaging such as optical coherence tomography (OCT), which can demonstrate macular hypoplasia, and visual electrophysiologic testing.
There is no cure for Down syndrome, so management focuses on supportive care and treatment of associated conditions. Early intervention programs, including speech therapy, occupational therapy, and educational support, significantly improve developmental outcomes. Ophthalmic issues such as strabismus or cataracts should be managed appropriately to optimize visual function.
Follow-up care is lifelong and multidisciplinary. With advances in medical care and supportive services, life expectancy has improved significantly, increasing from approximately 25 years in 1980 to nearly 50 years or more today. Many individuals now live into adulthood with improved quality of life, although neurodegenerative complications remain a concern later in life.
- Published on
Ophthalmology – Esotropia (Comitant)
Comitant esotropia is a form of strabismus in which one eye deviates inward toward the nose, with the key feature that the angle of deviation remains the same in all directions of gaze. It may be intermittent or constant and includes several subtypes such as accommodative, nonaccommodative, sensory, congenital/infantile, consecutive (after exotropia surgery), and cyclic esotropia. Rarely, it may be associated with systemic conditions such as ocular myasthenia gravis or thyroid eye disease.
This condition is relatively common in childhood, with an incidence of about 111 per 100,000 children under 19 years and a prevalence of approximately 2% in children under 6 years. Risk factors include hyperopia (farsightedness), poor vision in one or both eyes (sensory esotropia), prematurity, cerebral palsy, seizure disorders, and developmental delay. There is also a multifactorial genetic component, particularly in accommodative esotropia, where a strong family history is often present.
The pathophysiology depends on the subtype. In accommodative esotropia, excessive focusing effort to overcome hyperopia leads to increased convergence, resulting in inward deviation. In other forms, no clear abnormality in muscles or nerves is identified. Acute onset esotropia may raise concern for intracranial pathology such as tumors, Chiari malformation, or hydrocephalus.
Etiologically, accommodative esotropia is strongly linked to uncorrected hyperopia. Sensory esotropia arises when poor vision disrupts binocular alignment, often due to conditions like cataract or retinal disease. Acute comitant esotropia may indicate neurologic disease, and should prompt further evaluation.
Clinically, esotropia is often first noticed by parents in children, sometimes beginning intermittently and progressing to constant deviation. Symptoms may include crossed eyes, diplopia (in acute cases), or decreased vision. A history of neurologic issues, developmental delay, or prematurity may also be present.
On examination, a complete ophthalmic evaluation is essential. This includes cycloplegic refraction (often requiring atropine), assessment of ocular alignment in all gaze positions, and testing of stereoacuity. The AC/A ratio (accommodative convergence to accommodation) is particularly important in evaluating accommodative esotropia. Visual acuity testing is crucial to identify amblyopia, a common associated condition.
Diagnostic testing is usually not required unless atypical features are present. In suspected cases of myasthenia gravis, antibody testing or a Tensilon test may be performed. If thyroid eye disease is suspected, thyroid function tests are indicated. Neuroimaging (MRI of brain and orbits) is reserved for cases with acute onset or associated neurologic signs.
The differential diagnosis includes pseudoesotropia (common in infants with prominent epicanthal folds), incomitant esotropia, and systemic conditions like myasthenia gravis or thyroid eye disease.
Management depends on the cause. First-line treatment for accommodative esotropia is full correction of hyperopia with glasses or contact lenses, which often restores alignment. In cases with high AC/A ratio, bifocals may be required. Treatment of amblyopia with patching or atropine drops is critical.
Medications are generally not used, except in specific conditions such as myasthenia gravis. Vision therapy has no proven role in treatment.
Surgical intervention is indicated when alignment cannot be adequately controlled with optical correction. Procedures typically involve recession or resection of extraocular muscles, most commonly bilateral medial rectus recession. Surgery is usually performed on an outpatient basis.
Follow-up is essential, especially in children. Stable accommodative esotropia is typically monitored every 3–4 months, while more variable cases require closer observation. Parents should monitor eye alignment, and patients should report frequency of diplopia if present.
The prognosis varies by subtype. In accommodative esotropia, approximately one-third require lifelong glasses, one-third outgrow the need, and one-third eventually need surgery. Outcomes depend on early detection and treatment, particularly for preventing amblyopia. Acute cases depend on the underlying cause.
Complications include amblyopia and potential over- or undercorrection after surgery. Rare surgical risks include infection, hemorrhage, or muscle complications, though overall outcomes are generally favorable with appropriate management.
Comitant esotropia is a form of strabismus in which one eye deviates inward toward the nose, with the key feature that the angle of deviation remains the same in all directions of gaze. It may be intermittent or constant and includes several subtypes such as accommodative, nonaccommodative, sensory, congenital/infantile, consecutive (after exotropia surgery), and cyclic esotropia. Rarely, it may be associated with systemic conditions such as ocular myasthenia gravis or thyroid eye disease.
This condition is relatively common in childhood, with an incidence of about 111 per 100,000 children under 19 years and a prevalence of approximately 2% in children under 6 years. Risk factors include hyperopia (farsightedness), poor vision in one or both eyes (sensory esotropia), prematurity, cerebral palsy, seizure disorders, and developmental delay. There is also a multifactorial genetic component, particularly in accommodative esotropia, where a strong family history is often present.
The pathophysiology depends on the subtype. In accommodative esotropia, excessive focusing effort to overcome hyperopia leads to increased convergence, resulting in inward deviation. In other forms, no clear abnormality in muscles or nerves is identified. Acute onset esotropia may raise concern for intracranial pathology such as tumors, Chiari malformation, or hydrocephalus.
Etiologically, accommodative esotropia is strongly linked to uncorrected hyperopia. Sensory esotropia arises when poor vision disrupts binocular alignment, often due to conditions like cataract or retinal disease. Acute comitant esotropia may indicate neurologic disease, and should prompt further evaluation.
Clinically, esotropia is often first noticed by parents in children, sometimes beginning intermittently and progressing to constant deviation. Symptoms may include crossed eyes, diplopia (in acute cases), or decreased vision. A history of neurologic issues, developmental delay, or prematurity may also be present.
On examination, a complete ophthalmic evaluation is essential. This includes cycloplegic refraction (often requiring atropine), assessment of ocular alignment in all gaze positions, and testing of stereoacuity. The AC/A ratio (accommodative convergence to accommodation) is particularly important in evaluating accommodative esotropia. Visual acuity testing is crucial to identify amblyopia, a common associated condition.
Diagnostic testing is usually not required unless atypical features are present. In suspected cases of myasthenia gravis, antibody testing or a Tensilon test may be performed. If thyroid eye disease is suspected, thyroid function tests are indicated. Neuroimaging (MRI of brain and orbits) is reserved for cases with acute onset or associated neurologic signs.
The differential diagnosis includes pseudoesotropia (common in infants with prominent epicanthal folds), incomitant esotropia, and systemic conditions like myasthenia gravis or thyroid eye disease.
Management depends on the cause. First-line treatment for accommodative esotropia is full correction of hyperopia with glasses or contact lenses, which often restores alignment. In cases with high AC/A ratio, bifocals may be required. Treatment of amblyopia with patching or atropine drops is critical.
Medications are generally not used, except in specific conditions such as myasthenia gravis. Vision therapy has no proven role in treatment.
Surgical intervention is indicated when alignment cannot be adequately controlled with optical correction. Procedures typically involve recession or resection of extraocular muscles, most commonly bilateral medial rectus recession. Surgery is usually performed on an outpatient basis.
Follow-up is essential, especially in children. Stable accommodative esotropia is typically monitored every 3–4 months, while more variable cases require closer observation. Parents should monitor eye alignment, and patients should report frequency of diplopia if present.
The prognosis varies by subtype. In accommodative esotropia, approximately one-third require lifelong glasses, one-third outgrow the need, and one-third eventually need surgery. Outcomes depend on early detection and treatment, particularly for preventing amblyopia. Acute cases depend on the underlying cause.
Complications include amblyopia and potential over- or undercorrection after surgery. Rare surgical risks include infection, hemorrhage, or muscle complications, though overall outcomes are generally favorable with appropriate management.
- Published on
Ophthalmology – Episcleritis
Episcleritis is a benign, self-limited inflammatory condition affecting the episclera, the thin vascular layer just beneath the conjunctiva. It is typically mild, though it may be recurrent, and most commonly affects young adults, with a higher prevalence in females. Up to 30% of cases are associated with an underlying systemic condition.
There are two main clinical forms. Simple episcleritis presents with intermittent episodes of redness that resolve within 2–3 weeks. Nodular episcleritis is less common but tends to be more painful, prolonged, and characterized by a localized, raised inflammatory nodule. This form is more frequently associated with systemic disease.
The exact pathophysiology is not fully understood but is believed to involve a localized inflammatory response to an inciting trigger. The etiology is often idiopathic, though it may be associated with collagen vascular diseases (such as rheumatoid arthritis or lupus), infections (e.g., Lyme disease or syphilis), and other systemic conditions like gout or rosacea. Stress and hormonal changes have also been implicated.
Patients typically present with acute onset of redness, mild irritation, and tearing, often in a sectoral (localized) or diffuse pattern. Unlike more severe inflammatory conditions, pain is usually mild or absent, and vision is typically unaffected.
On examination, there is sectoral or diffuse conjunctival/episcleral injection, sometimes with a mobile, localized nodule. A key distinguishing feature is that the inflamed area can be moved over the sclera with a cotton-tipped applicator after topical anesthesia. Additionally, instillation of 2.5% phenylephrine drops causes blanching of the superficial vessels, helping differentiate episcleritis from deeper conditions like scleritis. About 10% of patients may have associated anterior uveitis, so a careful anterior segment exam is important.
Diagnosis is primarily clinical. Laboratory testing is not routinely required for isolated cases but should be considered in recurrent, severe, or nodular episcleritis, especially if systemic disease is suspected. Workup may include CBC, ESR, ANA, rheumatoid factor, uric acid levels, chest X-ray, and syphilis testing (VDRL, FTA-ABS).
The differential diagnosis includes conjunctivitis, scleritis (which is more painful and does not blanch with phenylephrine), and pingueculitis.
Management is usually conservative. First-line treatment includes artificial tears and cool compresses, which are often sufficient due to the self-limiting nature of the condition. For symptomatic relief, topical antihistamines or NSAIDs may be used. In more moderate cases, oral NSAIDs (e.g., indomethacin) or a short course of topical corticosteroids may be prescribed.
Follow-up is generally not required for isolated cases but is recommended for recurrent episodes or atypical presentations. Referral to an ophthalmologist is advised if there are corneal changes, persistent symptoms, or suspicion of underlying systemic disease.
The prognosis is excellent, with most cases resolving without complications. However, recurrence is common, and identifying any associated systemic condition is important for long-term management.
Episcleritis is a benign, self-limited inflammatory condition affecting the episclera, the thin vascular layer just beneath the conjunctiva. It is typically mild, though it may be recurrent, and most commonly affects young adults, with a higher prevalence in females. Up to 30% of cases are associated with an underlying systemic condition.
There are two main clinical forms. Simple episcleritis presents with intermittent episodes of redness that resolve within 2–3 weeks. Nodular episcleritis is less common but tends to be more painful, prolonged, and characterized by a localized, raised inflammatory nodule. This form is more frequently associated with systemic disease.
The exact pathophysiology is not fully understood but is believed to involve a localized inflammatory response to an inciting trigger. The etiology is often idiopathic, though it may be associated with collagen vascular diseases (such as rheumatoid arthritis or lupus), infections (e.g., Lyme disease or syphilis), and other systemic conditions like gout or rosacea. Stress and hormonal changes have also been implicated.
Patients typically present with acute onset of redness, mild irritation, and tearing, often in a sectoral (localized) or diffuse pattern. Unlike more severe inflammatory conditions, pain is usually mild or absent, and vision is typically unaffected.
On examination, there is sectoral or diffuse conjunctival/episcleral injection, sometimes with a mobile, localized nodule. A key distinguishing feature is that the inflamed area can be moved over the sclera with a cotton-tipped applicator after topical anesthesia. Additionally, instillation of 2.5% phenylephrine drops causes blanching of the superficial vessels, helping differentiate episcleritis from deeper conditions like scleritis. About 10% of patients may have associated anterior uveitis, so a careful anterior segment exam is important.
Diagnosis is primarily clinical. Laboratory testing is not routinely required for isolated cases but should be considered in recurrent, severe, or nodular episcleritis, especially if systemic disease is suspected. Workup may include CBC, ESR, ANA, rheumatoid factor, uric acid levels, chest X-ray, and syphilis testing (VDRL, FTA-ABS).
The differential diagnosis includes conjunctivitis, scleritis (which is more painful and does not blanch with phenylephrine), and pingueculitis.
Management is usually conservative. First-line treatment includes artificial tears and cool compresses, which are often sufficient due to the self-limiting nature of the condition. For symptomatic relief, topical antihistamines or NSAIDs may be used. In more moderate cases, oral NSAIDs (e.g., indomethacin) or a short course of topical corticosteroids may be prescribed.
Follow-up is generally not required for isolated cases but is recommended for recurrent episodes or atypical presentations. Referral to an ophthalmologist is advised if there are corneal changes, persistent symptoms, or suspicion of underlying systemic disease.
The prognosis is excellent, with most cases resolving without complications. However, recurrence is common, and identifying any associated systemic condition is important for long-term management.
- Published on
Ophthalmology – Epiretinal Membranes (ERM)
Epiretinal membranes (ERM), also known as macular pucker, cellophane maculopathy, or surface wrinkling retinopathy, are thin fibrocellular layers that form on the inner surface of the retina, particularly over the macula. While many cases are mild and asymptomatic, ERMs can distort the retinal architecture, leading to blurred vision and metamorphopsia (distorted vision). They are commonly associated with posterior vitreous detachment (PVD) and may coexist with vitreomacular traction.
ERM is primarily a disease of the elderly population, with prevalence increasing significantly with age. It is found in about 2% of individuals at age 50, rising to 20% by age 75. Although bilateral in 20–30% of cases, it is often asymmetric. Risk factors include female gender, aging, prior ocular surgery or trauma, diabetes, retinal vascular disease, intraocular inflammation, and vitreous hemorrhage. Pediatric cases are rare and usually secondary to other ocular abnormalities.
The pathophysiology involves abnormal proliferation of glial cells (including Müller cells, astrocytes, fibrocytes, and myofibroblasts) on the retinal surface. These cells often migrate after a posterior vitreous detachment, although they may appear earlier. Over time, these cells can acquire contractile properties, exerting traction on the retina and leading to wrinkling, distortion, and reduced visual acuity.
ERM can be classified as idiopathic (primary) or secondary. Idiopathic ERMs occur without an identifiable cause, while secondary ERMs develop in association with retinal vascular diseases, inflammation, trauma, or prior surgery.
Clinically, many patients are asymptomatic, especially in early stages. Symptomatic patients may report gradual vision loss, distortion of straight lines (metamorphopsia), difficulty reading, or central blurring. Occasionally, patients may experience diplopia or photopsias.
On examination, subtle ERMs may appear as a shiny, glistening reflex on the macula, while more advanced cases show retinal folds (striae), vessel tortuosity, and macular thickening. In some cases, cystoid macular edema (CME) or small hemorrhages may be present due to traction.
Diagnosis is primarily clinical but is best confirmed with imaging. Optical coherence tomography (OCT) is the gold standard and demonstrates retinal surface wrinkling, thickening, and possible cystoid changes. OCT also helps assess prognosis, as disruption of photoreceptor layers or significant edema correlates with poorer outcomes. Fluorescein angiography (FA) may be used to evaluate for underlying vascular disease or macular leakage. Amsler grid testing is useful for monitoring visual distortion.
The differential diagnosis includes proliferative diabetic retinopathy, retinal vein occlusion-related fibrosis, and incomplete posterior vitreous detachment with adherent posterior hyaloid.
Management depends on symptom severity. Asymptomatic patients require no treatment and can be observed with periodic follow-up. For patients with mild edema, topical NSAIDs or steroids may be used. However, medical therapy is generally limited in effectiveness for ERM itself.
Definitive treatment is surgical, indicated in patients with significant visual symptoms or visual acuity worse than ~20/40. The procedure involves pars plana vitrectomy with membrane peeling, often including removal of the internal limiting membrane (ILM) to reduce recurrence risk. Advances in minimally invasive vitrectomy have improved recovery times and outcomes.
Follow-up includes routine monitoring and Amsler grid use, with prompt reassessment if symptoms worsen. Many ERMs remain stable for years, but progression can occur, especially after acute PVD or ocular surgery.
The prognosis is generally favorable. Asymptomatic patients maintain good vision, while 80–90% of surgical patients experience improvement of at least two Snellen lines. However, complete restoration to normal vision (20/20) is uncommon, and outcomes depend largely on preoperative visual acuity and retinal integrity.
Complications include cataract formation (most common), retinal tears or detachment, recurrent ERM, retinal phototoxicity, and rarely endophthalmitis.
Epiretinal membranes (ERM), also known as macular pucker, cellophane maculopathy, or surface wrinkling retinopathy, are thin fibrocellular layers that form on the inner surface of the retina, particularly over the macula. While many cases are mild and asymptomatic, ERMs can distort the retinal architecture, leading to blurred vision and metamorphopsia (distorted vision). They are commonly associated with posterior vitreous detachment (PVD) and may coexist with vitreomacular traction.
ERM is primarily a disease of the elderly population, with prevalence increasing significantly with age. It is found in about 2% of individuals at age 50, rising to 20% by age 75. Although bilateral in 20–30% of cases, it is often asymmetric. Risk factors include female gender, aging, prior ocular surgery or trauma, diabetes, retinal vascular disease, intraocular inflammation, and vitreous hemorrhage. Pediatric cases are rare and usually secondary to other ocular abnormalities.
The pathophysiology involves abnormal proliferation of glial cells (including Müller cells, astrocytes, fibrocytes, and myofibroblasts) on the retinal surface. These cells often migrate after a posterior vitreous detachment, although they may appear earlier. Over time, these cells can acquire contractile properties, exerting traction on the retina and leading to wrinkling, distortion, and reduced visual acuity.
ERM can be classified as idiopathic (primary) or secondary. Idiopathic ERMs occur without an identifiable cause, while secondary ERMs develop in association with retinal vascular diseases, inflammation, trauma, or prior surgery.
Clinically, many patients are asymptomatic, especially in early stages. Symptomatic patients may report gradual vision loss, distortion of straight lines (metamorphopsia), difficulty reading, or central blurring. Occasionally, patients may experience diplopia or photopsias.
On examination, subtle ERMs may appear as a shiny, glistening reflex on the macula, while more advanced cases show retinal folds (striae), vessel tortuosity, and macular thickening. In some cases, cystoid macular edema (CME) or small hemorrhages may be present due to traction.
Diagnosis is primarily clinical but is best confirmed with imaging. Optical coherence tomography (OCT) is the gold standard and demonstrates retinal surface wrinkling, thickening, and possible cystoid changes. OCT also helps assess prognosis, as disruption of photoreceptor layers or significant edema correlates with poorer outcomes. Fluorescein angiography (FA) may be used to evaluate for underlying vascular disease or macular leakage. Amsler grid testing is useful for monitoring visual distortion.
The differential diagnosis includes proliferative diabetic retinopathy, retinal vein occlusion-related fibrosis, and incomplete posterior vitreous detachment with adherent posterior hyaloid.
Management depends on symptom severity. Asymptomatic patients require no treatment and can be observed with periodic follow-up. For patients with mild edema, topical NSAIDs or steroids may be used. However, medical therapy is generally limited in effectiveness for ERM itself.
Definitive treatment is surgical, indicated in patients with significant visual symptoms or visual acuity worse than ~20/40. The procedure involves pars plana vitrectomy with membrane peeling, often including removal of the internal limiting membrane (ILM) to reduce recurrence risk. Advances in minimally invasive vitrectomy have improved recovery times and outcomes.
Follow-up includes routine monitoring and Amsler grid use, with prompt reassessment if symptoms worsen. Many ERMs remain stable for years, but progression can occur, especially after acute PVD or ocular surgery.
The prognosis is generally favorable. Asymptomatic patients maintain good vision, while 80–90% of surgical patients experience improvement of at least two Snellen lines. However, complete restoration to normal vision (20/20) is uncommon, and outcomes depend largely on preoperative visual acuity and retinal integrity.
Complications include cataract formation (most common), retinal tears or detachment, recurrent ERM, retinal phototoxicity, and rarely endophthalmitis.
- Published on
Ophthalmology – Epiphora
Epiphora, commonly referred to as excessive tearing, results from an imbalance between tear production and tear drainage. Tears are produced by the lacrimal glands and normally drain through the nasolacrimal system into the nose. Any disruption in this balance—either overproduction due to irritation or impaired drainage due to obstruction—can lead to tearing.
Epidemiologically, epiphora shows a bimodal distribution, occurring most often in infants and older adults. In infants, the most common cause is congenital nasolacrimal duct obstruction, affecting about 5% of newborns, with 90% resolving spontaneously by age 1. In adults, tearing is frequently due to dry eye syndrome, particularly in postmenopausal women, where ocular surface irritation leads to reflex tearing.
The pathophysiology involves disruption of the normal tear film dynamics. Tears consist of aqueous, lipid, and mucin layers that maintain ocular surface health. Blinking helps pump tears into the drainage system. In infants, incomplete canalization of the nasolacrimal duct leads to obstruction. In adults, dry eye or tear film instability causes irritation and reflex tearing. Other contributors include blepharitis (affecting lipid layer), decreased tear production, eyelid malposition (e.g., ectropion), or obstruction from inflammation, trauma, or infection.
Etiologically, epiphora can be broadly divided into overproduction and outflow obstruction. Overproduction is usually secondary to ocular surface irritation, such as from trichiasis, entropion, keratitis, uveitis, conjunctivitis, or foreign bodies. Outflow obstruction may occur anywhere along the lacrimal drainage pathway due to infection (dacryocystitis), inflammation, trauma, or medication-induced stenosis. Poor tear pump function from eyelid laxity or facial nerve palsy may also contribute.
Clinically, infants present with constant tearing shortly after birth, often accompanied by crusting of eyelashes, especially after sleep, and symptoms may worsen with nasal congestion. Adults with dry eye typically report intermittent tearing, worsened by activities that reduce blinking (e.g., reading, screen use, driving) or environmental factors like wind and cold air. In contrast, patients with obstruction often have constant tearing and may have a history of infection or trauma.
Physical examination includes assessment of the tear film quality and quantity, eyelid position (looking for entropion, ectropion, or misdirected lashes), and ocular surface for signs of dry eye or inflammation. Evaluation of the lacrimal drainage system includes inspection of the puncta, canaliculi, and lacrimal sac, with palpation to check for reflux of discharge suggestive of obstruction or infection.
Diagnostic testing may include the fluorescein dye disappearance test, where persistence of dye suggests impaired drainage. Schirmer testing evaluates tear production, with less than 5 mm of wetting in 5 minutes indicating dry eye. Additional studies such as dacryocystography or lacrimal scintigraphy can help differentiate obstruction from pump failure. Imaging (CT scan) may be used if structural abnormalities, cysts, or tumors are suspected. Lacrimal irrigation in-office is a useful diagnostic tool in older children and adults.
The differential diagnosis varies by age. In children, causes include congenital nasolacrimal duct obstruction, congenital glaucoma, and epiblepharon. In adults, common causes include dry eye, nasolacrimal duct obstruction, eyelid malposition, trichiasis, and facial nerve palsy, while acute causes include conjunctivitis, keratitis, uveitis, or foreign body.
Management depends on the underlying cause. In infants, conservative treatment includes topical antibiotic ointment for discharge and lacrimal sac massage, which can help open the duct. Most cases resolve spontaneously. In adults with dry eye, artificial tears are first-line, with second-line options including topical cyclosporine or short-term steroids for inflammation. Acute causes require treatment of the underlying condition, such as antibiotics for infection or removal of a foreign body.
Procedural interventions include punctal occlusion for dry eye, punctoplasty for stenosis, and probing and irrigation for congenital obstruction. Surgical options such as dacryocystorhinostomy (DCR) are used for persistent nasolacrimal duct obstruction. Eyelid malpositions may require entropion or ectropion repair.
Follow-up varies by age and severity. Infants are typically observed during the first year, with surgery considered if symptoms persist beyond age 1. Adults are managed based on cause, with surgical follow-up as needed. Prognosis is excellent in pediatric cases, while in adults it depends on the underlying etiology—patients with obstruction often do well after surgery, whereas those with chronic dry eye may have ongoing intermittent symptoms.
Epiphora, commonly referred to as excessive tearing, results from an imbalance between tear production and tear drainage. Tears are produced by the lacrimal glands and normally drain through the nasolacrimal system into the nose. Any disruption in this balance—either overproduction due to irritation or impaired drainage due to obstruction—can lead to tearing.
Epidemiologically, epiphora shows a bimodal distribution, occurring most often in infants and older adults. In infants, the most common cause is congenital nasolacrimal duct obstruction, affecting about 5% of newborns, with 90% resolving spontaneously by age 1. In adults, tearing is frequently due to dry eye syndrome, particularly in postmenopausal women, where ocular surface irritation leads to reflex tearing.
The pathophysiology involves disruption of the normal tear film dynamics. Tears consist of aqueous, lipid, and mucin layers that maintain ocular surface health. Blinking helps pump tears into the drainage system. In infants, incomplete canalization of the nasolacrimal duct leads to obstruction. In adults, dry eye or tear film instability causes irritation and reflex tearing. Other contributors include blepharitis (affecting lipid layer), decreased tear production, eyelid malposition (e.g., ectropion), or obstruction from inflammation, trauma, or infection.
Etiologically, epiphora can be broadly divided into overproduction and outflow obstruction. Overproduction is usually secondary to ocular surface irritation, such as from trichiasis, entropion, keratitis, uveitis, conjunctivitis, or foreign bodies. Outflow obstruction may occur anywhere along the lacrimal drainage pathway due to infection (dacryocystitis), inflammation, trauma, or medication-induced stenosis. Poor tear pump function from eyelid laxity or facial nerve palsy may also contribute.
Clinically, infants present with constant tearing shortly after birth, often accompanied by crusting of eyelashes, especially after sleep, and symptoms may worsen with nasal congestion. Adults with dry eye typically report intermittent tearing, worsened by activities that reduce blinking (e.g., reading, screen use, driving) or environmental factors like wind and cold air. In contrast, patients with obstruction often have constant tearing and may have a history of infection or trauma.
Physical examination includes assessment of the tear film quality and quantity, eyelid position (looking for entropion, ectropion, or misdirected lashes), and ocular surface for signs of dry eye or inflammation. Evaluation of the lacrimal drainage system includes inspection of the puncta, canaliculi, and lacrimal sac, with palpation to check for reflux of discharge suggestive of obstruction or infection.
Diagnostic testing may include the fluorescein dye disappearance test, where persistence of dye suggests impaired drainage. Schirmer testing evaluates tear production, with less than 5 mm of wetting in 5 minutes indicating dry eye. Additional studies such as dacryocystography or lacrimal scintigraphy can help differentiate obstruction from pump failure. Imaging (CT scan) may be used if structural abnormalities, cysts, or tumors are suspected. Lacrimal irrigation in-office is a useful diagnostic tool in older children and adults.
The differential diagnosis varies by age. In children, causes include congenital nasolacrimal duct obstruction, congenital glaucoma, and epiblepharon. In adults, common causes include dry eye, nasolacrimal duct obstruction, eyelid malposition, trichiasis, and facial nerve palsy, while acute causes include conjunctivitis, keratitis, uveitis, or foreign body.
Management depends on the underlying cause. In infants, conservative treatment includes topical antibiotic ointment for discharge and lacrimal sac massage, which can help open the duct. Most cases resolve spontaneously. In adults with dry eye, artificial tears are first-line, with second-line options including topical cyclosporine or short-term steroids for inflammation. Acute causes require treatment of the underlying condition, such as antibiotics for infection or removal of a foreign body.
Procedural interventions include punctal occlusion for dry eye, punctoplasty for stenosis, and probing and irrigation for congenital obstruction. Surgical options such as dacryocystorhinostomy (DCR) are used for persistent nasolacrimal duct obstruction. Eyelid malpositions may require entropion or ectropion repair.
Follow-up varies by age and severity. Infants are typically observed during the first year, with surgery considered if symptoms persist beyond age 1. Adults are managed based on cause, with surgical follow-up as needed. Prognosis is excellent in pediatric cases, while in adults it depends on the underlying etiology—patients with obstruction often do well after surgery, whereas those with chronic dry eye may have ongoing intermittent symptoms.
- Published on
Ophthalmology – Entropion
Entropion is defined as an inward rotation of the eyelid margin, causing the eyelashes and periocular skin to rub against the ocular surface. This results in chronic irritation and can lead to corneal damage if untreated. It may be classified into four types: congenital, involutional (most common), spastic, and cicatricial.
Epidemiologically, involutional entropion increases with age and is the most frequently encountered type. Spastic entropion is typically temporary, often triggered by trauma, ocular irritation, or blepharospasm. Cicatricial entropion is less common but more severe, frequently associated with ocular cicatricial pemphigoid (OCP), which tends to affect older adults (age 60–70) and occurs more often in females. OCP has a prevalence of approximately 1 in 15,000–20,000 individuals.
The pathophysiology involves multiple mechanical and structural changes. These include increased orbicularis muscle tone and override, weakening or dehiscence of the lower eyelid retractors, horizontal eyelid laxity, and atrophy of the tarsal plate. In cicatricial cases, scarring of the conjunctiva leads to inward rotation of the lid margin.
Etiologically, entropion may result from aging changes, chronic use of certain topical medications (e.g., pilocarpine, timolol, epinephrine), or systemic autoimmune conditions such as ocular cicatricial pemphigoid, a type II hypersensitivity reaction with genetic predisposition (associated with HLA-DQB1*0301). Other associated conditions include Stevens–Johnson syndrome, trachoma, trauma, and chemical burns, all of which can lead to conjunctival scarring.
Patients typically present with foreign body sensation, tearing, redness, and irritation.
On examination, the eyelid margin is visibly inverted, with eyelashes rubbing against the cornea. Findings may include conjunctival injection, superficial punctate keratopathy, corneal abrasions, and in advanced cases, corneal scarring, thinning, ulceration, or neovascularization. In cicatricial entropion, additional features such as symblepharon (adhesion between palpebral and bulbar conjunctiva) and forniceal shortening may be present.
Diagnosis is primarily clinical. Laboratory testing is generally not required unless an autoimmune etiology such as OCP is suspected. In such cases, conjunctival biopsy with immunofluorescence can confirm the diagnosis, showing antibody deposition in over 80% of cases. Ancillary markers such as ANA or inflammatory mediators may also be elevated.
The differential diagnosis includes conditions that mimic eyelash irritation, such as epiblepharon (common in children), trichiasis (misdirected lashes), and distichiasis (extra row of lashes).
Management initially focuses on protecting the ocular surface. First-line treatment includes frequent lubrication with artificial tears and ointments. Temporary measures such as taping the lower eyelid to the cheek may help reposition the lid. In cases associated with OCP, systemic immunosuppressive therapy (e.g., prednisone, methotrexate, cyclophosphamide) may be required.
Definitive treatment is surgical, and most patients will eventually require it. Procedures include horizontal eyelid tightening, retractor repair, orbicularis muscle repositioning, or marginal rotation techniques. Simple suture repairs can be performed but have a higher recurrence rate.
Close follow-up is essential, typically within one week, to monitor for corneal complications. Patients should be educated to seek urgent care if they experience increased pain, redness, tearing, or photophobia, as these may indicate corneal involvement.
The prognosis is generally good with timely surgical correction. However, cicatricial causes like OCP may follow a chronic relapsing course and can lead to progressive vision loss if not adequately managed. Serious complications include corneal ulceration, scarring, perforation, and even loss of the eye, making early recognition and treatment critical.
- Published on
Ophthalmology – Enophthalmos
Enophthalmos refers to the posterior displacement of a normal-sized globe within the orbit, giving the appearance of a “sunken eye.” It can be congenital or acquired, with acquired causes being more common in clinical practice. The condition may develop gradually or suddenly, depending on the underlying etiology, and can be unilateral or bilateral.
The underlying pathophysiology depends on the cause. Congenital enophthalmos results from abnormal orbital development during fetal life. Acquired forms arise from mechanisms such as loss of orbital volume (fat atrophy), structural changes in the orbit (e.g., fractures or sinus disease), or fibrotic traction pulling the globe backward. Enlargement of the orbital cavity or loss of support from the orbital floor may also lead to associated hypoglobus (downward displacement of the globe).
Etiologically, enophthalmos can be grouped into three major categories: structural abnormalities, fat atrophy, and tractional causes. Common causes include orbital floor fractures, especially following trauma, postsurgical changes (such as orbital decompression or tumor removal), and silent sinus syndrome, where chronic maxillary sinus collapse leads to orbital floor descent. Other causes include orbital fat atrophy (e.g., due to radiation or systemic wasting), metastatic scirrhous carcinoma (notably breast cancer) causing fibrotic contraction, and orbital venous malformations. Neurologic and congenital conditions such as Duane retraction syndrome may also be associated.
Patients often report a gradual sinking of the eye or asymmetry in appearance. Some may notice a droopy eyelid or deepened upper eyelid sulcus, and historical photographs can be useful for comparison. On examination, key findings include deepened superior sulcus, narrowed palpebral fissure, and posterior displacement of the globe. Measurement with Hertel exophthalmometry can help quantify asymmetry, although it may be less useful in bilateral cases. Additional findings such as skin thinning (in atrophy) or thickening (in malignancy), as well as ocular motility or sensory deficits, may provide clues to the underlying cause. A full ocular exam is essential to assess visual acuity and optic nerve function, including evaluation for an afferent pupillary defect.
Imaging plays a crucial role in diagnosis. A CT scan of the orbits (axial and coronal views) is the primary modality to evaluate bony structures and orbital volume changes. If inflammatory or neoplastic causes are suspected, an MRI with contrast and fat suppression is indicated. In uncertain cases, orbital biopsy (orbitotomy) may be required for definitive diagnosis.
The differential diagnosis includes pseudo-enophthalmos, where the globe appears sunken but is actually normal in position. Causes include contralateral proptosis, Horner syndrome, phthisis bulbi, and microphthalmos.
Management depends on the underlying etiology. Orbital fractures may require surgical repair to restore orbital volume. Silent sinus syndrome is treated with functional endoscopic sinus surgery to re-aerate the sinus. In cases of volume loss, orbital augmentation with implants or fillers (e.g., hyaluronic acid) may be used. Oncologic causes require appropriate systemic evaluation and treatment.
Follow-up involves monitoring by an ophthalmologist, and in cases involving sinus disease, collaboration with an otolaryngologist is important. Patients should be advised to avoid nose blowing or forceful sneezing (with a closed mouth), particularly if an orbital fracture is suspected.
Chronic enophthalmos can be difficult to fully correct, especially if longstanding, and may lead to persistent cosmetic and functional concerns if not addressed early.
Enophthalmos refers to the posterior displacement of a normal-sized globe within the orbit, giving the appearance of a “sunken eye.” It can be congenital or acquired, with acquired causes being more common in clinical practice. The condition may develop gradually or suddenly, depending on the underlying etiology, and can be unilateral or bilateral.
The underlying pathophysiology depends on the cause. Congenital enophthalmos results from abnormal orbital development during fetal life. Acquired forms arise from mechanisms such as loss of orbital volume (fat atrophy), structural changes in the orbit (e.g., fractures or sinus disease), or fibrotic traction pulling the globe backward. Enlargement of the orbital cavity or loss of support from the orbital floor may also lead to associated hypoglobus (downward displacement of the globe).
Etiologically, enophthalmos can be grouped into three major categories: structural abnormalities, fat atrophy, and tractional causes. Common causes include orbital floor fractures, especially following trauma, postsurgical changes (such as orbital decompression or tumor removal), and silent sinus syndrome, where chronic maxillary sinus collapse leads to orbital floor descent. Other causes include orbital fat atrophy (e.g., due to radiation or systemic wasting), metastatic scirrhous carcinoma (notably breast cancer) causing fibrotic contraction, and orbital venous malformations. Neurologic and congenital conditions such as Duane retraction syndrome may also be associated.
Patients often report a gradual sinking of the eye or asymmetry in appearance. Some may notice a droopy eyelid or deepened upper eyelid sulcus, and historical photographs can be useful for comparison. On examination, key findings include deepened superior sulcus, narrowed palpebral fissure, and posterior displacement of the globe. Measurement with Hertel exophthalmometry can help quantify asymmetry, although it may be less useful in bilateral cases. Additional findings such as skin thinning (in atrophy) or thickening (in malignancy), as well as ocular motility or sensory deficits, may provide clues to the underlying cause. A full ocular exam is essential to assess visual acuity and optic nerve function, including evaluation for an afferent pupillary defect.
Imaging plays a crucial role in diagnosis. A CT scan of the orbits (axial and coronal views) is the primary modality to evaluate bony structures and orbital volume changes. If inflammatory or neoplastic causes are suspected, an MRI with contrast and fat suppression is indicated. In uncertain cases, orbital biopsy (orbitotomy) may be required for definitive diagnosis.
The differential diagnosis includes pseudo-enophthalmos, where the globe appears sunken but is actually normal in position. Causes include contralateral proptosis, Horner syndrome, phthisis bulbi, and microphthalmos.
Management depends on the underlying etiology. Orbital fractures may require surgical repair to restore orbital volume. Silent sinus syndrome is treated with functional endoscopic sinus surgery to re-aerate the sinus. In cases of volume loss, orbital augmentation with implants or fillers (e.g., hyaluronic acid) may be used. Oncologic causes require appropriate systemic evaluation and treatment.
Follow-up involves monitoring by an ophthalmologist, and in cases involving sinus disease, collaboration with an otolaryngologist is important. Patients should be advised to avoid nose blowing or forceful sneezing (with a closed mouth), particularly if an orbital fracture is suspected.
Chronic enophthalmos can be difficult to fully correct, especially if longstanding, and may lead to persistent cosmetic and functional concerns if not addressed early.
- Published on
Ophthalmology – Endophthalmitis
Endophthalmitis is a severe, vision-threatening intraocular inflammatory condition involving the vitreous and aqueous humors, most commonly due to infection. It is considered an ophthalmic emergency, as rapid progression can lead to permanent vision loss or blindness. The condition is broadly classified into infectious (postoperative, posttraumatic, or endogenous) and noninfectious (sterile) forms, the latter mimicking infection clinically.
Most cases are postoperative (approximately 75%), particularly following cataract surgery, with an incidence of about 0.05–0.16%. Posttraumatic cases account for about 20%, often associated with penetrating injuries or retained intraocular foreign bodies. Endogenous cases (around 5%) occur when infection spreads hematogenously from a distant systemic source, typically in immunocompromised individuals, intravenous drug users, or patients with indwelling catheters.
The pathophysiology involves rapid microbial proliferation within the vitreous cavity, followed by a robust inflammatory response. Within 24 hours, inflammatory cells infiltrate ocular tissues, and by 48 hours, irreversible photoreceptor damage may occur. Even after microbial control, inflammatory mediators and endotoxins may continue to damage intraocular structures.
Patients typically present with acute onset of eye pain, decreased vision, and redness, often with a history of recent surgery, trauma, or systemic infection. Examination findings may include conjunctival injection, corneal edema, hypopyon (layering of pus in the anterior chamber), anterior chamber inflammation, and dense vitreitis, often obscuring the view of the retina. Postoperative and traumatic cases are usually unilateral, while endogenous cases may be bilateral.
Diagnosis is primarily clinical but supported by investigations. A vitreous tap is performed to obtain samples for Gram stain, culture, and fungal studies. In suspected endogenous cases, blood and urine cultures may help identify the systemic source, and an echocardiogram may be required to rule out endocarditis. B-scan ultrasonography is useful when the retina cannot be visualized, helping detect vitreous inflammation or retinal detachment.
Management requires urgent intravitreal antibiotic therapy, targeting both Gram-positive and Gram-negative organisms. Common regimens include vancomycin and ceftazidime, often combined with intravitreal corticosteroids to reduce inflammation. In suspected fungal infections, intravitreal antifungal agents are used. Patients with very poor vision (light perception only) typically require pars plana vitrectomy, which removes infected vitreous material and improves drug penetration.
Close monitoring is essential, often requiring daily follow-up until stabilization. Additional treatments may include repeat intravitreal injections or delayed vitrectomy if response is inadequate. Endogenous cases require systemic evaluation and treatment of the underlying infection, often in collaboration with infectious disease specialists.
Despite advances in treatment, the prognosis remains guarded, with a significant risk of permanent vision impairment or blindness. Early diagnosis and prompt intervention greatly improve outcomes. Complications include retinal detachment and phthisis bulbi, both of which can lead to irreversible vision loss.
Endophthalmitis is a severe, vision-threatening intraocular inflammatory condition involving the vitreous and aqueous humors, most commonly due to infection. It is considered an ophthalmic emergency, as rapid progression can lead to permanent vision loss or blindness. The condition is broadly classified into infectious (postoperative, posttraumatic, or endogenous) and noninfectious (sterile) forms, the latter mimicking infection clinically.
Most cases are postoperative (approximately 75%), particularly following cataract surgery, with an incidence of about 0.05–0.16%. Posttraumatic cases account for about 20%, often associated with penetrating injuries or retained intraocular foreign bodies. Endogenous cases (around 5%) occur when infection spreads hematogenously from a distant systemic source, typically in immunocompromised individuals, intravenous drug users, or patients with indwelling catheters.
The pathophysiology involves rapid microbial proliferation within the vitreous cavity, followed by a robust inflammatory response. Within 24 hours, inflammatory cells infiltrate ocular tissues, and by 48 hours, irreversible photoreceptor damage may occur. Even after microbial control, inflammatory mediators and endotoxins may continue to damage intraocular structures.
Patients typically present with acute onset of eye pain, decreased vision, and redness, often with a history of recent surgery, trauma, or systemic infection. Examination findings may include conjunctival injection, corneal edema, hypopyon (layering of pus in the anterior chamber), anterior chamber inflammation, and dense vitreitis, often obscuring the view of the retina. Postoperative and traumatic cases are usually unilateral, while endogenous cases may be bilateral.
Diagnosis is primarily clinical but supported by investigations. A vitreous tap is performed to obtain samples for Gram stain, culture, and fungal studies. In suspected endogenous cases, blood and urine cultures may help identify the systemic source, and an echocardiogram may be required to rule out endocarditis. B-scan ultrasonography is useful when the retina cannot be visualized, helping detect vitreous inflammation or retinal detachment.
Management requires urgent intravitreal antibiotic therapy, targeting both Gram-positive and Gram-negative organisms. Common regimens include vancomycin and ceftazidime, often combined with intravitreal corticosteroids to reduce inflammation. In suspected fungal infections, intravitreal antifungal agents are used. Patients with very poor vision (light perception only) typically require pars plana vitrectomy, which removes infected vitreous material and improves drug penetration.
Close monitoring is essential, often requiring daily follow-up until stabilization. Additional treatments may include repeat intravitreal injections or delayed vitrectomy if response is inadequate. Endogenous cases require systemic evaluation and treatment of the underlying infection, often in collaboration with infectious disease specialists.
Despite advances in treatment, the prognosis remains guarded, with a significant risk of permanent vision impairment or blindness. Early diagnosis and prompt intervention greatly improve outcomes. Complications include retinal detachment and phthisis bulbi, both of which can lead to irreversible vision loss.
